Mario Gabelli Organon & Co. Transaction History

Gamco Investors, Inc. Et Al

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$13.78 - $18.8 $895 - $1,222	-65 Reduced 0.3%	21,372 $401,000
Q3 2022 Nov 10, 2022	SELL	$23.4 - $34.25 $46,800 - $68,500	-2,000 Reduced 8.53%	21,437 $502,000
Q2 2022 Aug 12, 2022	SELL	$31.66 - $38.9 $94,980 - $116,700	-3,000 Reduced 11.35%	23,437 $791,000
Q1 2022 May 18, 2022	BUY	$30.45 - $39.36 $805,006 - $1.04 Million	26,437 New	26,437 $923,000
Q1 2022 May 13, 2022	SELL	$30.45 - $39.36 $1.11 Million - $1.43 Million	-36,437 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$28.63 - $35.64 $46,867 - $58,342	1,637 Added 4.7%	36,437 $1.2 Million
Q2 2021 Aug 13, 2021	BUY	$28.45 - $38.0 $990,060 - $1.32 Million	34,800 New	34,800 $1.05 Million

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.79B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Gamco Investors, Inc. Et Al, based on Form 13F filings with the SEC.

Stay updated on Gamco Investors, Inc. Et Al and Mario Gabelli with notifications on news.